These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 28005986)
1. A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted. Neumann PJ; Thorat T; Zhong Y; Anderson J; Farquhar M; Salem M; Sandberg E; Saret CJ; Wilkinson C; Cohen JT PLoS One; 2016; 11(12):e0168512. PubMed ID: 28005986 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania. Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251 [TBL] [Abstract][Full Text] [Related]
3. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB Lancet; 1999 Sep; 354(9181):803-9. PubMed ID: 10485721 [TBL] [Abstract][Full Text] [Related]
4. Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies. Leech AA; Kim DD; Cohen JT; Neumann PJ Value Health; 2018 Jul; 21(7):759-761. PubMed ID: 30005746 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data. Fernandes S; Sicuri E; Kayentao K; van Eijk AM; Hill J; Webster J; Were V; Akazili J; Madanitsa M; ter Kuile FO; Hanson K Lancet Glob Health; 2015 Mar; 3(3):e143-53. PubMed ID: 25701992 [TBL] [Abstract][Full Text] [Related]
6. Comparing the cost-per-QALYs gained and cost-per-DALYs averted literatures. Neumann PJ; Anderson JE; Panzer AD; Pope EF; D'Cruz BN; Kim DD; Cohen JT Gates Open Res; 2018; 2():5. PubMed ID: 29431169 [No Abstract] [Full Text] [Related]
7. Cost-Effectiveness of Exploratory Laparotomy in a Regional Referral Hospital in Eastern Uganda. Bellamkonda N; Motwani G; Wange AH; De Boer C; Kirya F; Juillard C; Marseille E; Ajiko MM; Dicker RA J Surg Res; 2020 Jan; 245():587-592. PubMed ID: 31499364 [TBL] [Abstract][Full Text] [Related]
8. Newborn screening and prophylactic interventions for sickle cell disease in 47 countries in sub-Saharan Africa: a cost-effectiveness analysis. Kuznik A; Habib AG; Munube D; Lamorde M BMC Health Serv Res; 2016 Jul; 16():304. PubMed ID: 27461265 [TBL] [Abstract][Full Text] [Related]
9. Scaling up integrated prevention campaigns for global health: costs and cost-effectiveness in 70 countries. Marseille E; Jiwani A; Raut A; Verguet S; Walson J; Kahn JG BMJ Open; 2014 Jun; 4(6):e003987. PubMed ID: 24969782 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of interventions for HIV/AIDS, malaria, syphilis, and tuberculosis in 128 countries: a meta-regression analysis. Silke F; Earl L; Hsu J; Janko MM; Joffe J; Memetova A; Michael D; Zheng P; Aravkin A; Murray CJL; Weaver MR Lancet Glob Health; 2024 Jul; 12(7):e1159-e1173. PubMed ID: 38876762 [TBL] [Abstract][Full Text] [Related]
11. [Cost-effectiveness of public health practices: a literature review of public health interventions from the Mesoamerican Health Initiative]. Valencia-Mendoza A; Danese-dlSantos LG; Sosa-Rubí SG; Aracena-Genao B Salud Publica Mex; 2011; 53 Suppl 3():S375-85. PubMed ID: 22344382 [TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries. Hogan DR; Baltussen R; Hayashi C; Lauer JA; Salomon JA BMJ; 2005 Dec; 331(7530):1431-7. PubMed ID: 16282380 [TBL] [Abstract][Full Text] [Related]
13. Orthopaedic trauma care in Haiti: a cost-effectiveness analysis of an innovative surgical residency program. Carlson LC; Slobogean GP; Pollak AN Value Health; 2012; 15(6):887-93. PubMed ID: 22999139 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of health systems strengthening interventions in improving maternal and child health in low- and middle-income countries: a systematic review. Zeng W; Li G; Ahn H; Nguyen HTH; Shepard DS; Nair D Health Policy Plan; 2018 Mar; 33(2):283-297. PubMed ID: 29253136 [TBL] [Abstract][Full Text] [Related]
15. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa. Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749 [TBL] [Abstract][Full Text] [Related]
16. Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia. Tesfaye A; Fiseha D; Assefa D; Klinkenberg E; Balanco S; Langley I BMC Infect Dis; 2017 May; 17(1):318. PubMed ID: 28464797 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of medical primary prevention strategies to reduce absolute risk of cardiovascular disease in Tanzania: a Markov modelling study. Ngalesoni FN; Ruhago GM; Mori AT; Robberstad B; Norheim OF BMC Health Serv Res; 2016 May; 16():185. PubMed ID: 27184802 [TBL] [Abstract][Full Text] [Related]
18. Use of DALYs in economic analyses on interventions for infectious diseases: a systematic review. Oostvogels AJ; De Wit GA; Jahn B; Cassini A; Colzani E; De Waure C; Kretzschmar ME; Siebert U; Mühlberger N; Mangen MJ Epidemiol Infect; 2015 Jul; 143(9):1791-802. PubMed ID: 25499823 [TBL] [Abstract][Full Text] [Related]
19. Cost Per DALY Averted in a Surgical Unit of a Private Hospital in India. Chatterjee S; Laxminarayan R; Gosselin RA World J Surg; 2016 May; 40(5):1034-40. PubMed ID: 26675929 [TBL] [Abstract][Full Text] [Related]
20. Cost effectiveness analysis of strategies for tuberculosis control in developing countries. Baltussen R; Floyd K; Dye C BMJ; 2005 Dec; 331(7529):1364. PubMed ID: 16282379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]